Inhibiting endoplasmic reticulum stress alleviates perioperative neurocognitive disorders by reducing neuroinflammation mediated by <scp>NLRP3</scp> inflammasome activation

Fanbing Meng, Jian Song, Xinwei Huang, Meixian Zhang, Xiaoxiao Sun, Qi Jing, Silu Cao, Zheng Xie, Qiong Liu, Hui Zhang, Cheng LiCNS 2024 · DOI

TL;DR

Anesthesia and surgery (A/S) can lead to perioperative neurocognitive disorders (PND), a significant problem in aging populations. This study reveals that endoplasmic reticulum (ER) stress, triggered by A/S, drives neuroinflammation via NLRP3 inflammasome activation, causing cognitive decline. Importantly, inhibiting ER stress with TUDCA before A/S effectively prevented these cognitive deficits and reduced neuroinflammation.

What Problem Does This Paper Address?

As the global population ages, more individuals undergo anesthesia and surgery (A/S). A common and concerning consequence of A/S is perioperative neurocognitive disorders (PND), characterized by memory and cognitive decline, particularly in older adults. Despite its prevalence and impact (leading to increased medical costs and risk of dementia), there's no established pharmacological treatment for PND, and its underlying molecular mechanisms remain unclear. Previous research has implicated neuroinflammation, driven by microglia and astrocytes, in PND. Additionally, ER stress, a cellular response to protein misfolding, is known to be involved in neurodegenerative diseases and cognitive impairment. However, the direct link between ER stress and NLRP3 inflammasome activation in the context of A/S-induced PND was not well understood. This paper aims to bridge this knowledge gap by exploring the key mechanisms of PND after A/S, focusing on the role of ER stress and NLRP3 inflammasome activation.

Methods

The researchers employed a multi-pronged approach using aged mice (18 months old) to model PND.

  • Transcriptome Sequencing (RNA-seq): Hippocampal samples from control and A/S groups were analyzed to identify differentially expressed genes (DEGs).
  • Bioinformatics Analysis: Metascape was used for functional enrichment analysis of DEGs, and a combination of protein-protein interaction (PPI) network analysis (using STRING and CytoHubba) and weighted gene coexpression network analysis (WGCNA) was used to screen for "hub genes" – genes that play a central role in the observed molecular changes.
  • Molecular Validation: Quantitative reverse transcription PCR (qRT-PCR) and Western blotting were used to confirm changes in mRNA and protein expression of key genes.
  • Inflammasome Assessment: Western blotting and ELISA were used to measure the activation of the NLRP3 inflammasome and the levels of inflammatory cytokines (IL-1β and IL-18).
  • Intervention Study: Tauroursodeoxycholic acid (TUDCA), an ER stress inhibitor, was administered preoperatively to assess its therapeutic effects.
  • Neuroinflammation Assessment: Immunofluorescence staining was used to evaluate the activation of astrocytes and microglia in the hippocampus.
  • Behavioral Tests: A battery of tests, including the open field test, Barnes maze, and contextual fear conditioning, were used to assess motor activity, anxiety, learning, and memory.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • A/S Induces ER Stress and Neuroinflammation: The study clearly demonstrates that A/S in aged mice leads to significant ER stress (indicated by increased Hspa5 and Xbp1 expression) and activation of the NLRP3 inflammasome in the hippocampus.
  • ER Stress is a Driver of NLRP3 Activation: A critical finding is that ER stress, not just a consequence, appears to be a key trigger for NLRP3 inflammasome activation in the context of A/S-induced PND. This suggests a direct mechanistic link.
  • TUDCA as a Protective Agent: Preoperative administration of TUDCA, an ER stress inhibitor, effectively mitigated A/S-induced cognitive deficits, reduced neuroinflammation (by decreasing microglial and astrocytic activation), and suppressed NLRP3 inflammasome activation. This highlights a potential therapeutic strategy.
  • Hub Genes as Biomarkers/Targets: The identification of hub genes like Hspa5 and Xbp1, which are directly linked to ER stress, provides potential biomarkers for PND or targets for future therapeutic interventions.

Key Results

  • DEGs and Functional Enrichment: 521 differentially expressed genes (DEGs) were identified between control and A/S groups, with a significant enrichment in terms related to metabolic processes and their regulation.
  • Hub Gene Identification: Four key hub genes (Hspa5, Igf1r, Sfpq, and Xbp1) were identified, with Hspa5 and Xbp1 showing remarkable upregulation after A/S.
  • Cognitive Impairment: Mice subjected to A/S exhibited significant cognitive impairments in learning and memory tasks (Barnes maze, fear conditioning).
  • Inflammasome Activation: A/S led to increased expression of NLRP3, pro-caspase-1, cleaved-caspase-1, and elevated levels of IL-1β and IL-18 in the hippocampus.
  • TUDCA Efficacy: TUDCA treatment significantly reversed the cognitive deficits, reduced the activation of microglia and astrocytes, and attenuated the upregulation of ER stress markers (GRP78, XBP1) and NLRP3 inflammasome components.

Limitations and Future Work

The authors acknowledge several limitations:

  • Mechanism of ER Stress-Induced NLRP3 Activation: The precise molecular mechanisms by which ER stress triggers NLRP3 activation remain to be fully elucidated.
  • Cell-Type Specificity: The study did not definitively pinpoint which specific hippocampal cell types (neurons, microglia, or astrocytes) are primarily involved in ER stress-induced NLRP3 inflammasome activation.
  • Inhibition vs. Knockout: While TUDCA (an inhibitor) was used, the study did not employ genetic approaches like NLRP3 knockout mice to further confirm the role of NLRP3.

Future research directions suggested include:

  • Investigating the detailed molecular mechanisms underlying the ER stress-NLRP3 inflammasome crosstalk.
  • Clarifying the specific cellular contributions of neurons, microglia, and astrocytes to this process.
  • Conducting studies with NLRP3 knockout models to solidify the findings.
  • Exploring the potential role of mitochondrial dysfunction, particularly mitophagy, in PND, given its connection to ER stress and mitochondria.

Summary updated

Abstract

Inhibiting ER stress alleviated cognitive impairment in A/S mice; particularly, ER stress induced by A/S results in NLRP3 inflammasome activation and neuroinflammation. Moreover, the preoperative administration of TUDCA inhibited ER stress, NLRP3 inflammasome activation, and neuroinflammation.
BibTeX
@inproceedings{meng2024inhibiting,
  author = {Fanbing Meng and Jian Song and Xinwei Huang and Meixian Zhang and Xiaoxiao Sun and Qi Jing and Silu Cao and Zheng Xie and Qiong Liu and Hui Zhang and Cheng Li},
  title = {{Inhibiting endoplasmic reticulum stress alleviates perioperative neurocognitive disorders by reducing neuroinflammation mediated by <scp>NLRP3</scp> inflammasome activation}},
  booktitle = {CNS},
  year = {2024},
  doi = {10.1111/cns.70049},
}
Figure